Drug therapy: cerebral vasodilators (first of two parts).
D000368:Aged; D000375:Aging; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000503:physiopathology; D002986:Clinical Trials as Topic; D003495:Cyclandelate / Q000494:pharmacology / Q000627:therapeutic use; D003704:Dementia / Q000188:drug therapy* / Q000503:physiopathology; D006592:Hexobendine / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D009257:Nafronyl / Q000494:pharmacology / Q000627:therapeutic use; D010208:Papaverine / Q000494:pharmacology / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use*
D014665:Vasodilator Agents; D003495:Cyclandelate; D009257:Nafronyl; D006592:Hexobendine; D010208:Papaverine